Literature DB >> 23873916

Effects of low PBP2b levels on cell morphology and peptidoglycan composition in Streptococcus pneumoniae R6.

Kari Helene Berg1, Gro Anita Stamsås, Daniel Straume, Leiv Sigve Håvarstein.   

Abstract

Streptococcus pneumoniae produces two class B penicillin-binding proteins, PBP2x and PBP2b, both of which are essential. It is generally assumed that PBP2x is specifically involved in septum formation, while PBP2b is dedicated to peripheral cell wall synthesis. However, little experimental evidence exists to substantiate this belief. In the present study, we obtained evidence that strongly supports the view that PBP2b is essential for peripheral peptidoglycan synthesis. Depletion of PBP2b expression gave rise to long chains of cells in which individual cells were compressed in the direction of the long axis and looked lentil shaped. This morphological change is consistent with a role for pneumococcal PBP2b in the synthesis of the lateral cell wall. Depletion of PBP2x, on the other hand, resulted in lemon-shaped and some elongated cells with a thickened midcell region. Low PBP2b levels gave rise to changes in the peptidoglycan layer that made pneumococci sensitive to exogenously added LytA during logarithmic growth and refractory to chain dispersion upon addition of LytB. Interestingly, analysis of the cell wall composition of PBP2b-depleted pneumococci revealed that they had a larger proportion of branched stem peptides in their peptidoglycan than the corresponding undepleted cells. Furthermore, MurM-deficient mutants, i.e., mutants lacking the ability to synthesize branched muropeptides, were found to require much higher levels of PBP2b to sustain growth than those required by MurM-proficient strains. These findings might help to explain why increased incorporation of branched muropeptides is required for high-level beta-lactam resistance in S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873916      PMCID: PMC3807472          DOI: 10.1128/JB.00184-13

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  40 in total

1.  Characterization of the murMN operon involved in the synthesis of branched peptidoglycan peptides in Streptococcus pneumoniae.

Authors:  S R Filipe; M G Pinho; A Tomasz
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

2.  A novel multifunctional labeling reagent for enhanced protein characterization with mass spectrometry.

Authors:  E C Peters; D M Horn; D C Tully; A Brock
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

3.  A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics.

Authors:  Detlev Suckau; Anja Resemann; Martin Schuerenberg; Peter Hufnagel; Jochen Franzen; Armin Holle
Journal:  Anal Bioanal Chem       Date:  2003-06-27       Impact factor: 4.142

Review 4.  Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets.

Authors:  Lok-To Sham; Ho-Ching T Tsui; Adrian D Land; Skye M Barendt; Malcolm E Winkler
Journal:  Curr Opin Microbiol       Date:  2012-01-24       Impact factor: 7.934

5.  Streptococcus pneumoniae R6 interspecies transformation: genetic analysis of penicillin resistance determinants and genome-wide recombination events.

Authors:  Julia Sauerbier; Patrick Maurer; Martin Rieger; Regine Hakenbeck
Journal:  Mol Microbiol       Date:  2012-09-12       Impact factor: 3.501

6.  Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

7.  An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae.

Authors:  C K Sung; H Li; J P Claverys; D A Morrison
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

8.  Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes.

Authors:  S R Filipe; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

9.  The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated beta-lactam resistance.

Authors:  B Weber; K Ehlert; A Diehl; P Reichmann; H Labischinski; R Hakenbeck
Journal:  FEMS Microbiol Lett       Date:  2000-07-01       Impact factor: 2.742

10.  LytA, major autolysin of Streptococcus pneumoniae, requires access to nascent peptidoglycan.

Authors:  Peter Mellroth; Robert Daniels; Alice Eberhardt; Daniel Rönnlund; Hans Blom; Jerker Widengren; Staffan Normark; Birgitta Henriques-Normark
Journal:  J Biol Chem       Date:  2012-02-09       Impact factor: 5.157

View more
  37 in total

1.  Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.

Authors:  Ozden Kocaoglu; Ho-Ching T Tsui; Malcolm E Winkler; Erin E Carlson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

2.  Requirement of essential Pbp2x and GpsB for septal ring closure in Streptococcus pneumoniae D39.

Authors:  Adrian D Land; Ho-Ching T Tsui; Ozden Kocaoglu; Stephen A Vella; Sidney L Shaw; Susan K Keen; Lok-To Sham; Erin E Carlson; Malcolm E Winkler
Journal:  Mol Microbiol       Date:  2013-10-17       Impact factor: 3.501

3.  Penicillin-binding protein 2x of Streptococcus pneumoniae: the mutation Ala707Asp within the C-terminal PASTA2 domain leads to destabilization.

Authors:  Inga Schweizer; Katharina Peters; Christoph Stahlmann; Regine Hakenbeck; Dalia Denapaite
Journal:  Microb Drug Resist       Date:  2014-05-19       Impact factor: 3.431

Review 4.  The elongation of ovococci.

Authors:  Jules Philippe; Thierry Vernet; André Zapun
Journal:  Microb Drug Resist       Date:  2014-04-28       Impact factor: 3.431

5.  Absence of the KhpA and KhpB (JAG/EloR) RNA-binding proteins suppresses the requirement for PBP2b by overproduction of FtsA in Streptococcus pneumoniae D39.

Authors:  Jiaqi J Zheng; Amilcar J Perez; Ho-Ching Tiffany Tsui; Orietta Massidda; Malcolm E Winkler
Journal:  Mol Microbiol       Date:  2017-11-02       Impact factor: 3.501

6.  Roles of the Essential Protein FtsA in Cell Growth and Division in Streptococcus pneumoniae.

Authors:  Andrea Mura; Daniela Fadda; Amilcar J Perez; Madeline L Danforth; Daniela Musu; Ana Isabel Rico; Marcin Krupka; Dalia Denapaite; Ho-Ching T Tsui; Malcolm E Winkler; Pavel Branny; Miguel Vicente; William Margolin; Orietta Massidda
Journal:  J Bacteriol       Date:  2017-01-12       Impact factor: 3.490

7.  Suppression and synthetic-lethal genetic relationships of ΔgpsB mutations indicate that GpsB mediates protein phosphorylation and penicillin-binding protein interactions in Streptococcus pneumoniae D39.

Authors:  Britta E Rued; Jiaqi J Zheng; Andrea Mura; Ho-Ching T Tsui; Michael J Boersma; Jeffrey L Mazny; Federico Corona; Amilcar J Perez; Daniela Fadda; Linda Doubravová; Karolína Buriánková; Pavel Branny; Orietta Massidda; Malcolm E Winkler
Journal:  Mol Microbiol       Date:  2017-02-07       Impact factor: 3.501

8.  Mechanism of β-lactam action in Streptococcus pneumoniae: the piperacillin paradox.

Authors:  Jules Philippe; Benoit Gallet; Cécile Morlot; Dalia Denapaite; Regine Hakenbeck; Yuxin Chen; Thierry Vernet; André Zapun
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

9.  Pbp2x localizes separately from Pbp2b and other peptidoglycan synthesis proteins during later stages of cell division of Streptococcus pneumoniae D39.

Authors:  Ho-Ching T Tsui; Michael J Boersma; Stephen A Vella; Ozden Kocaoglu; Erkin Kuru; Julia K Peceny; Erin E Carlson; Michael S VanNieuwenhze; Yves V Brun; Sidney L Shaw; Malcolm E Winkler
Journal:  Mol Microbiol       Date:  2014-08-21       Impact factor: 3.501

Review 10.  β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.